Use of Chicken Embryo Model in Toxicity Studies of Endocrine-Disrupting Chemicals and Nanoparticles

被引:14
作者
Ghimire, Shweta [1 ]
Zhang, Xinwen [1 ]
Zhang, Jinglin [1 ]
Wu, Changqing [1 ]
机构
[1] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA
基金
美国国家科学基金会; 美国食品与农业研究所;
关键词
MESSENGER-RNA EXPRESSION; CHORIOALLANTOIC MEMBRANE CAM; ZEBRAFISH DANIO-RERIO; BISPHENOL-A; IN-VITRO; OXIDATIVE STRESS; COPPER NANOPARTICLES; CARBON NANOPARTICLES; DNA-DAMAGE; EXPOSURE;
D O I
10.1021/acs.chemrestox.1c00399
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lab animals such as mice and rats are widely used in toxicity research of food additive and pharmaceutics, despite the well-recognized research limitation such as the inability to simulate human neurological diseases, faster absorption of chemicals, big variations among species, and high cost when using a large number of animals. The Society of Toxicology's guidance now focuses on minimizing discomfort and distress of lab animals, finding alternative ways to reduce animal number, replacing animals with in vitro models, and complying to the animal welfare policies. The chicken embryonic model can be a better alternative to mice and rats because of its abundant availability and cost-effectiveness. It can be studied in both laboratory and natural environment, with easy manipulation in ovo or in vivo. The objective of this review paper is to evaluate the use of chicken embryonic model in toxicity evaluation for endocrine-disrupting chemicals (EDCs) and nanoparticles (NPs) by different end points to determine more comprehensive toxic responses. The end points include chicken embryonic mortality and hatchability, developmental malformation analysis, hormonal imbalance, physiological changes in endocrine organs, and antiangiogenesis. Major research methodologies using chicken embryos are also summarized to demonstrate their versatile practice and valuable application in modern toxicity evaluation of EDCs and NPs.
引用
收藏
页码:550 / 568
页数:19
相关论文
共 125 条
[1]  
Agency for Toxic Substances and Disease Registry (ATSDR), 2011, EV MERC EXP INF HLTH, P1
[2]  
Asadi A., 2019, HORIZ MED SCI, V25, P270, DOI DOI 10.32598/HMS.25.4.270
[3]  
AUERBACH R, 1976, CANCER RES, V36, P3435
[4]   Anti-Angiogenesis Effect of Biogenic Silver Nanoparticles Synthesized Using Saliva officinalis on Chick Chorioalantoic Membrane (CAM) [J].
Baharara, Javad ;
Namvar, Farideh ;
Mousavi, Marzieh ;
Ramezani, Tayebe ;
Mohamad, Rosfarizan .
MOLECULES, 2014, 19 (09) :13498-13508
[5]   Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model [J].
Beedie, Shaunna L. ;
Mahony, Chris ;
Walker, Heather M. ;
Chau, Cindy H. ;
Figg, William D. ;
Vargesson, Neil .
SCIENTIFIC REPORTS, 2016, 6
[6]   Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients [J].
Bernardes, Sara Santos ;
de Souza-Neto, Fernando Pinheiro ;
Zambelli Ramalho, Leandra Naira ;
Derossi, Daniela Rudgeri ;
Guarnier, Flavia Alessandra ;
Nunes da Silva, Cassio Fernando ;
Melo, Gabriella Pascoal ;
Colado Simao, Andrea Name ;
Cecchini, Rubens ;
Cecchini, Alessandra Lourenco .
CANCER LETTERS, 2015, 361 (01) :226-232
[7]   In Ovo Administration of Silver Nanoparticles and/or Amino Acids Influence Metabolism and Immune Gene Expression in Chicken Embryos [J].
Bhanja, Subrat K. ;
Hotowy, Anna ;
Mehra, Manish ;
Sawosz, Ewa ;
Pineda, Lane ;
Vadalasetty, Krishna Prasad ;
Kurantowicz, Natalia ;
Chwalibog, Andre .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (05) :9484-9503
[8]   Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer [J].
Binh Thanh Vu ;
Shahin, Sophia Allaf ;
Croissant, Jonas ;
Fatieiev, Yevhen ;
Matsumoto, Kotaro ;
Doan, Tan Le-Hoang ;
Yik, Tammy ;
Simargi, Shirleen ;
Conteras, Altagracia ;
Ratliff, Laura ;
Jimenez, Chiara Mauriello ;
Raehm, Laurence ;
Khashab, Niveen ;
Durand, Jean-Olivier ;
Glackin, Carlotta ;
Tamanoi, Fuyuhiko .
SCIENTIFIC REPORTS, 2018, 8
[9]   Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model [J].
Bobek, V ;
Plachy, J ;
Pinterova, D ;
Kolostova, K ;
Boubelik, M ;
Jiang, P ;
Yang, M ;
Hoffman, RM .
CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (04) :347-352
[10]  
Bowman Linda, 2012, Methods Mol Biol, V906, P415, DOI 10.1007/978-1-61779-953-2_34